Largest Part of Population with OSAH Remains Undiagnosed, Says Black Swan Analysis in Its Report Published at MarketPublishers.com
27 Dec 2016 • by Natalie Aster
LONDON – The prevalence rates of the obstructive sleep apnea in adults (obstructive sleep apnea-hypopnea (OSAH) are estimated in the range of 3% to 7%, with specific population subgroups carrying higher risks. Factors increasing vulnerability for the disorder encompass, among others, sex, obesity, age, menopause, family history, craniofacial abnormalities, and certain health behaviours like alcohol abuse and cigarette smoking.
In spite of the numerous advances in the understanding of the pathogenesis and clinical outcomes of the disease, the better part of those affected are still undiagnosed. Elementary queries of the patient or bed-partner for the signs and symptoms of OSAH, such as loud frequent snoring, apparent apneas, and diurnal drowsiness, would assist in the identification of those that need further diagnostic evaluation.
New comprehensive report “Epiomic Epidemiology Series: Adult Obstructive Sleep Apnoea Forecast in 8 Major Markets 2016-2026” developed by Black Swan Analysis gives an all-round assessment of the current situation in the OSAH market across the USA, France, Germany, Italy, Spain, the UK, Japan and Brazil; the updated estimates are split based on gender and 5-year age cohort. It discusses the current OSAH prevalence rates; examines the risk factors, disorder diagnosis and prognosis as well as specific variations by ethnicity and geographic region. The study limelights the main symptoms and co-morbidities of the disease; reviews and forecasts to 2026 sub-populations within the main disease country-wise; and presents accurate, unbiased information for clinical trials. Furthermore, the research report provides future outlook for the OSAH market across the leading 8 countries.
More insightful studies elaborated by Black Swan Analysis are provided at its page.